Zhouliang Wu

647 total citations
51 papers, 455 citations indexed

About

Zhouliang Wu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Zhouliang Wu has authored 51 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Surgery, 19 papers in Pulmonary and Respiratory Medicine and 15 papers in Molecular Biology. Recurrent topics in Zhouliang Wu's work include Bladder and Urothelial Cancer Treatments (27 papers), Urinary and Genital Oncology Studies (13 papers) and Ferroptosis and cancer prognosis (10 papers). Zhouliang Wu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (27 papers), Urinary and Genital Oncology Studies (13 papers) and Ferroptosis and cancer prognosis (10 papers). Zhouliang Wu collaborates with scholars based in China, United States and Germany. Zhouliang Wu's co-authors include Dawei Tian, Changli Wu, Linguo Xie, Hailong Hu, Chong Shen, Wanqin Xie, Hao Xu, Nan Sha, Guangjun Nie and Yu Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Zhouliang Wu

45 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhouliang Wu China 12 226 175 106 81 60 51 455
Amir Zamani Iran 5 209 0.9× 86 0.5× 63 0.6× 38 0.5× 92 1.5× 7 483
Linhua Yang China 13 323 1.4× 187 1.1× 118 1.1× 61 0.8× 114 1.9× 25 515
Liying He China 8 269 1.2× 173 1.0× 109 1.0× 31 0.4× 29 0.5× 10 480
Guangyan Lei China 9 108 0.5× 75 0.4× 77 0.7× 56 0.7× 79 1.3× 20 290
Yufei Zhao China 12 164 0.7× 80 0.5× 50 0.5× 45 0.6× 94 1.6× 55 413
Jianli Hu China 11 207 0.9× 168 1.0× 26 0.2× 36 0.4× 97 1.6× 16 398
Juntao Huang China 12 119 0.5× 83 0.5× 60 0.6× 92 1.1× 71 1.2× 39 317
Haoming Xia China 13 253 1.1× 215 1.2× 24 0.2× 48 0.6× 51 0.8× 21 390
Miaozun Zhang China 14 198 0.9× 120 0.7× 159 1.5× 180 2.2× 204 3.4× 29 520
Guiming Shu China 8 225 1.0× 148 0.8× 52 0.5× 28 0.3× 27 0.5× 11 434

Countries citing papers authored by Zhouliang Wu

Since Specialization
Citations

This map shows the geographic impact of Zhouliang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhouliang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhouliang Wu more than expected).

Fields of papers citing papers by Zhouliang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhouliang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhouliang Wu. The network helps show where Zhouliang Wu may publish in the future.

Co-authorship network of co-authors of Zhouliang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhouliang Wu. A scholar is included among the top collaborators of Zhouliang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhouliang Wu. Zhouliang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wu, Zhouliang, Zefang Lu, Feilong Qi, et al.. (2025). Selective apoptosis of tumor-associated platelets boosts the anti-metastatic potency of PD-1 blockade therapy. Cell Reports Medicine. 6(3). 101984–101984.
3.
Shen, Chong, Jian Guo, Wei Su, et al.. (2025). Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer. Frontiers in Immunology. 15. 1430583–1430583. 3 indexed citations
4.
Liu, Cong, Xiuhua Liu, Yipei Wang, et al.. (2025). An oxazinone-based fluorescent probe for detection of endogenous esterase and application in diagnosis of liver cancer. Microchemical Journal. 209. 112868–112868. 1 indexed citations
5.
6.
Zhang, Xiuping, Bozhao Li, Zefang Lu, et al.. (2023). Nanoparticle-based combination of LMWH and doxorubicin for the efficient treatment of hepatocellular carcinoma with portal vein tumor thrombus. Nano Today. 49. 101787–101787. 6 indexed citations
7.
8.
Niu, Yuanjie, et al.. (2023). Outcomes of renal function and efficacy in patients with muscle invasive bladder cancer treated by tislelizumab-based immunochemotherapy.. Journal of Clinical Oncology. 41(16_suppl). e16608–e16608.
9.
Zhang, Zhe, Lei Wang, Zhouliang Wu, et al.. (2023). Enhancing urinary tract infection diagnosis for negative culture patients with metagenomic next-generation sequencing (mNGS). Frontiers in Cellular and Infection Microbiology. 13. 1119020–1119020. 17 indexed citations
10.
Hu, Hailong, et al.. (2023). A novel approach to the treatment of high-risk non–muscle-invasive bladder cancer: Combining immune checkpoint inhibitor (ICI) and microtubule inhibitor (MTI).. Journal of Clinical Oncology. 41(16_suppl). e16596–e16596. 1 indexed citations
11.
Shen, Chong, Zhi Li, Zhe Zhang, et al.. (2022). Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer. Frontiers in Oncology. 12. 1018285–1018285. 10 indexed citations
12.
Zhang, Xiuping, Xiangjun Chen, Bozhao Li, et al.. (2022). Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence. Biomaterials. 281. 121362–121362. 37 indexed citations
13.
Li, Fan, et al.. (2021). Circ_0030586 inhibits cell proliferation and stemness in bladder cancer by inactivating the ERK signaling via miR-665/NR4A3 axis. Acta Histochemica. 123(5). 151745–151745. 15 indexed citations
14.
Zhang, Bo, Jing Li, Zhouliang Wu, et al.. (2020). Contrast-Enhanced Ultrasound Characteristics of Renal Pelvis Urothelial Carcinoma and Its Relationship with Microvessel Density. Ultrasound in Medicine & Biology. 47(2). 236–243. 2 indexed citations
15.
16.
Tang, Gang, Zhiyong Du, Chuan Qin, et al.. (2017). Risk factors of renal function after radical nephroureterectomy for upper tract urothelial carcinoma. Zhonghua miniao waike zazhi. 38(9). 692–697. 1 indexed citations
17.
Zhang, Bo, Zhouliang Wu, Wanqin Xie, et al.. (2017). The expression of vasohibin-1 and its prognostic significance in bladder cancer. Experimental and Therapeutic Medicine. 14(4). 3477–3484. 8 indexed citations
18.
Xie, Linguo, Wanqin Xie, Hailong Hu, et al.. (2016). The comparison of perioperative outcomes of robot-assisted and open partial nephrectomy: a systematic review and meta-analysis. World Journal of Surgical Oncology. 14(1). 220–220. 34 indexed citations
19.
20.
Wu, Changli, Nan Sha, Linguo Xie, et al.. (2015). Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection. OncoTargets and Therapy. 8. 3401–3401. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amir Zamani Breakdown of academic impact, for papers by Linhua Yang Breakdown of academic impact, for papers by Liying He Breakdown of academic impact, for papers by Guangyan Lei Breakdown of academic impact, for papers by Yufei Zhao Breakdown of academic impact, for papers by Jianli Hu Breakdown of academic impact, for papers by Juntao Huang Breakdown of academic impact, for papers by Haoming Xia Breakdown of academic impact, for papers by Miaozun Zhang Breakdown of academic impact, for papers by Guiming Shu
Rankless by CCL
2026